SCHEMBL8778995

SCHEMBL8778995

Nc1ccc2c(c1)C(=O)C1(CCCC1)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.43
HTR2A P28223 7/20 0.43
HTR2C P28335 7/20 0.43
HTR2B P41595 7/20 0.43
CA9 Q16790 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TYMS P04818 1/20 0.38
DRD2 P14416 7/20 0.38
CRBN Q96SW2 1/20 0.35
MAPK1 P28482 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779005 0.80 MAPT (0.33) CA9CASP1CASP7HSD17B10TYMS
SCHEMBL8779101 0.80 TDP1 (0.50) SIGMAR1HTR2AHTR2CHTR2BCA9
SCHEMBL22892512 0.80 SIGMAR1 (0.46) SIGMAR1HTR2AHTR2CHTR2BCA9
SCHEMBL8779154 0.80 PARP1 (0.46) SIGMAR1HTR2AHTR2CHTR2BCA9
SCHEMBL8779128 0.80 F7 (0.46) SIGMAR1HTR2AHTR2CHTR2BTYMS
SCHEMBL8779110 0.80 SIGMAR1 (0.43) SIGMAR1HTR2AHTR2CHTR2BTYMS
SCHEMBL8913172 0.79 SIGMAR1 (0.47) SIGMAR1HTR2AHTR2CHTR2BCASP1
SCHEMBL27463810 0.78 CA9 (0.41) SIGMAR1HTR2AHTR2CHTR2BCA9
SCHEMBL6841622 0.77 SIGMAR1 (0.62) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779124 0.76 HTR2A (0.51) SIGMAR1HTR2AHTR2CHTR2BCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed